Cargando…
Role of endothelial cells in graft-versus-host disease
To date, the only curative treatment for high-risk or refractory hematologic malignancies non-responsive to standard chemotherapy is allogeneic hematopoietic transplantation (allo-HCT). Acute graft-versus-host disease (GVHD) is a donor T cell-mediated immunological disorder that is frequently fatal...
Autores principales: | Neidemire-Colley, Lotus, Robert, Jérémy, Ackaoui, Antoine, Dorrance, Adrienne M., Guimond, Martin, Ranganathan, Parvathi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727380/ https://www.ncbi.nlm.nih.gov/pubmed/36505438 http://dx.doi.org/10.3389/fimmu.2022.1033490 |
Ejemplares similares
-
Corrigendum: Role of endothelial cells in graft-versus-host disease
por: Neidemire-Colley, Lotus, et al.
Publicado: (2023) -
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease
por: Snyder, Katiri J., et al.
Publicado: (2021) -
Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice
por: Dorrance, Adrienne M., et al.
Publicado: (2022) -
Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease
por: Zitzer, Nina C., et al.
Publicado: (2018) -
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease
por: Apostolova, Petya, et al.
Publicado: (2016)